Literature DB >> 9822364

State-specific prevalence among adults of current cigarette smoking and smokeless tobacco use and per capita tax-paid sales of cigarettes--United States, 1997.

.   

Abstract

In the United States each year, tobacco use causes approximately 400,000 deaths and is the single most preventable cause of death and disease. Consequently, state and local public health agencies closely monitor tobacco use and its correlates. In 1996, the prevalence of current cigarette smoking among adults was the first health behavior and the first noninfectious condition added by the Council of State and Territorial Epidemiologists (CSTE) to the list of nationally notifiable conditions reported to CDC. In 1998, per capita sales of cigarettes (along with prevalence among youth of current cigarette smoking and current smokeless tobacco use) was added by CSTE to the list of notifiable conditions reported by states to CDC. This report summarizes state-specific findings for current cigarette and current smokeless tobacco use by adults from the Behavioral Risk Factor Surveillance System (BRFSS) and number of packs of tax-paid cigarettes sold per capita in each state from data compiled annually by The Tobacco Institute. The findings indicate that current adult cigarette smoking prevalence by state ranged from 13.7% to 30.8%, annual per capita tax-paid cigarette sales ranged from 49.1 packs to 186.8 packs, and adult smokeless tobacco use prevalence ranged from 1.4% to 8.8%.

Entities:  

Mesh:

Year:  1998        PMID: 9822364

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

1.  Tobacco use characteristics among rural Ohio Appalachians.

Authors:  M E Wewers; K L Ahijevych; M S Chen; S Dresbach; K E Kihm; P A Kuun
Journal:  J Community Health       Date:  2000-10

2.  Spit (Smokeless)-Tobacco Use by Baseball Players Entering the Professional Ranks.

Authors:  Jeff Cooper; James A. Ellison; Margaret M. Walsh
Journal:  J Athl Train       Date:  2003-06       Impact factor: 2.860

3.  Cost-effectiveness in Preventive Cardiology.

Authors:  William S. Weintraub
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-08

4.  Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results?

Authors:  S-H Zhu; J B Wang; A Hartman; Y Zhuang; A Gamst; J T Gibson; H Gilljam; M R Galanti
Journal:  Tob Control       Date:  2009-01-23       Impact factor: 7.552

Review 5.  Estrogen receptor pathways in lung cancer.

Authors:  Laura P Stabile; Jill M Siegfried
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.